Dysadipocytokinemia in werner syndrome and its recovery by treatment with pioglitazone [4] (multiple letter)

Diabetes Care

Volumn 27, Issue 10, 2004, Pages 2562-2563

  Yokote, Koutaro ^a,b   Hara, Kazuo ^c   Mori, Seijiro ^a,b   Kadowaki, Takashi ^c   Saito, Yasushi ^a,b   Goto, Makoto ^d,e  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d Tokyo Metropolitan Ohtsuka Hospital   (Japan)

^e TOIN UNIVERSITY OF YOKOHAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; CYTOKINE; INSULIN; LEPTIN; PIOGLITAZONE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; WERNER SYNDROME PROTEIN;

ADIPOCYTE; ADULT; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; WERNER SYNDROME;

ADIPOCYTES; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; THIAZOLIDINEDIONES; TREATMENT OUTCOME; WERNER SYNDROME;

EID: 4644328933     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.10.2562     Document Type: Letter

References (5)

1. Goto M: Clinical characteristics of Werner syndrome and other premature aging syndromes: pattern of aging in progeroid syndromes. In From Premature Cray Hair to Helicase-Wemer Syndrome: Implication for Aging and Cancer. Goto M, Miller RW, Eds. Basel, Karger, 2001, p. 27-39
2. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946, 2001
3. Mori S, Murano S, Yokote K, Takemoto M, Asaumi S, Take A, Saito Y: Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome. Int J Obes Relat Metab Disord 25:292-295, 2001
4. Daimon M, Oizumi T, Saitoh T, Yamaguchi H, Hirata A, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M: Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population. Diabetes Care 26:2015-2020, 2003
5. Yokote K, Honjo S, Kobayashi K, Fujimoto M, Kawamura H, Mori S, Saito Y: Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone (Letter). 52:1582-1583, 2004